{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:40:22Z","timestamp":1793997622796,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016807","name":"Natural Science Foundation of Shenyang Municipality","doi-asserted-by":"publisher","award":["23-503-6-11"],"award-info":[{"award-number":["23-503-6-11"]}],"id":[{"id":"10.13039\/100016807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273878"],"award-info":[{"award-number":["82273878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473872"],"award-info":[{"award-number":["82473872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biomaterials.2025.123294","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:03:27Z","timestamp":1743120207000},"page":"123294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["STING-activating layered double hydroxide nano-adjuvants for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"321","author":[{"given":"Lirui","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-5052","authenticated-orcid":false,"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40820-023-01125-2","article-title":"Application of nano-delivery systems in lymph nodes for tumor immunotherapy","volume":"15","author":"Xia","year":"2023","journal-title":"Nano-Micro Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12951-023-01977-1","article-title":"Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123294_bib3","first-page":"911","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Can."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123294_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090972","article-title":"Adjuvants and antigen-delivery systems for subunit vaccines against tuberculosis","volume":"9","author":"Mustafa","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2025.123294_bib6","article-title":"Oncolytic adenovirus: prospects for cancer immunotherapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J. Inflamm."},{"key":"10.1016\/j.biomaterials.2025.123294_bib8","article-title":"Lymph node targeting for immunotherapy","volume":"20","author":"Wang","year":"2023","journal-title":"Immunooncol. Technol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123294_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2025.123294_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41590-019-0342-0","article-title":"Lymph node conduits transport virions for rapid T cell activation","volume":"20","author":"Reynoso","year":"2019","journal-title":"Nat. Immunol."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123294_bib13","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1158\/1078-0432.CCR-09-0645","article-title":"Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors","volume":"15","author":"Smith","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123294_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215205","article-title":"Role of immunotherapy in the treatment of cancer: a systematic review","volume":"14","author":"Ling","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-019-1266-0","article-title":"Advances in cancer immunotherapy 2019 - latest trends","volume":"38","author":"Kruger","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2025.123294_bib16","first-page":"406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2012","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123294_bib17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Gar\u00e7on","year":"2007","journal-title":"Expert Rev. Vaccines"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123294_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.11.23","article-title":"MF59 adjuvant: the best insurance against influenza strain diversity","volume":"10","author":"Derek","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123294_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123294_bib21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123294_bib22","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123294_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtm.2020.07.015","article-title":"Barriers and strategies of cationic liposomes for cancer gene therapy","volume":"18","author":"Liu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.biomaterials.2025.123294_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.actbio.2015.10.025","article-title":"Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages","volume":"29","author":"Lee","year":"2016","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123294_bib25","article-title":"Improving STING agonist delivery for cancer immunotherapy using biodegradable mesoporous silica nanoparticles","volume":"3","author":"Park","year":"2020","journal-title":"Adv. Ther."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123294_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/polym14153090","article-title":"Novel nanotechnology-based approaches for targeting HIV reservoirs","volume":"14","author":"Fotooh Abadi","year":"2022","journal-title":"Polymers"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123294_bib27","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1039\/b106465g","article-title":"Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide","author":"Khan","year":"2001","journal-title":"Chem. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123294_bib28","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1021\/cr200434v","article-title":"Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets","volume":"112","author":"Wang","year":"2012","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123294_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-5861(91)80068-K","article-title":"Hydrotalcite-type anionic clays: preparation, properties and applications","volume":"11","author":"Cavani","year":"1991","journal-title":"Catal. Today"},{"key":"10.1016\/j.biomaterials.2025.123294_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2019.122232","article-title":"Chlorogenic acid intercalated Gadolinium\u2013Zinc\/Aluminium layered double hydroxide and gold nanohybrid for MR imaging and drug delivery","volume":"240","author":"Usman","year":"2020","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.biomaterials.2025.123294_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clay.2018.08.020","article-title":"The prospect of layered double hydroxide as bone implants: a study of mechanical properties, cytocompatibility and antibacterial activity","volume":"165","author":"Peng","year":"2018","journal-title":"Appl. Clay Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2008.05.021","article-title":"Subcellular compartment targeting of layered double hydroxide nanoparticles","volume":"130","author":"Xu","year":"2008","journal-title":"J. Contr. Release"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123294_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202200299","article-title":"Two-dimensional ultra-thin nanosheets with extraordinarily high drug loading and long blood circulation for cancer therapy","volume":"18","author":"Zhang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123294_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jconrel.2023.01.043","article-title":"Engineered NanoAlum from aluminum turns cold tumor hot for potentiating cancer metalloimmunotherapy","volume":"354","author":"Jia","year":"2023","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123294_bib35","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1021\/acsnano.2c02183","article-title":"Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking tumor cell autophagy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123294_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100923","article-title":"Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11426-020-9933-4","article-title":"Two-dimensional LDH nanodisks modified with hyaluronidase enable enhanced tumor penetration and augmented chemotherapy","volume":"64","author":"Li","year":"2021","journal-title":"Sci. China Chem."},{"issue":"31","key":"10.1016\/j.biomaterials.2025.123294_bib38","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1039\/C7TB00819H","article-title":"MgAl-layered double hydroxide nanoparticles co-delivering siIDO and Trp2 peptide effectively reduce IDO expression and induce cytotoxic T-lymphocyte responses against melanoma tumor in mice","volume":"5","author":"Zhang","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123294_bib39","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1096\/fj.12-218362","article-title":"Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine","volume":"27","author":"Pusic","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.biomaterials.2025.123294_bib40","first-page":"1","article-title":"Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant","author":"Neto","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123294_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137010","article-title":"Iron released after cryo-thermal therapy induced M1 macrophage polarization, promoting the differentiation of CD4(+) T cells into CTLs","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123294_bib42","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1007\/s12274-022-4282-x","article-title":"STING and TLR7\/8 agonists-based nanovaccines for synergistic antitumor immune activation","volume":"15","author":"Zhang","year":"2022","journal-title":"Nano Res."},{"issue":"283","key":"10.1016\/j.biomaterials.2025.123294_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4306","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","volume":"7","author":"Fu","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123294_bib44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2025.123294_bib45","article-title":"Advances of MnO(2) nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123294_bib46","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123294_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123294_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125107","article-title":"The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells","volume":"4","author":"Gutjahr","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123294_bib49","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123294_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099988","article-title":"DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization","volume":"9","author":"Downey","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123294_bib52","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/0008-5472.CAN-15-1885","article-title":"Agonist-mediated activation of STING induces apoptosis in malignant B cells","volume":"76","author":"Tang","year":"2016","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123294_bib53","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1039\/C5TB00248F","article-title":"Pre-coating layered double hydroxide nanoparticles with albumin to improve colloidal stability and cellular uptake","volume":"3","author":"Gu","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40495-017-0097-y","article-title":"Evolving insights for MHC class II antigen processing and presentation in health and disease","volume":"3","author":"Duffy","year":"2017","journal-title":"Curr. Pharmacol. Rep."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123294_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib56","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123294_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123294_bib58","first-page":"327","article-title":"Nanoparticle vaccines, vaccine","volume":"32","author":"Zhao","year":"2014"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123294_bib59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","article-title":"Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biomaterials.2025.123294_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669566","article-title":"Ironing out the details: how iron orchestrates macrophage polarization","volume":"12","author":"Xia","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib61","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123294_bib62","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/bjh.15753","article-title":"Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma","volume":"185","author":"Chu","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123294_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/13543784.17.1.23","article-title":"The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer","volume":"17","author":"McKeage","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123294_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1628","article-title":"Disrupting tumour blood vessels","volume":"5","author":"Tozer","year":"2005","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:32:33Z","timestamp":1777782753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"alternative-id":["S0142961225002133"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123294","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING-activating layered double hydroxide nano-adjuvants for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123294"}}